Over the past 12 months, 2 insiders at Certara, Inc. filed 2 open-market SEC Form 4 transactions on CERT: 1 purchase worth $200K and 1 sale worth $559K. Insiders have been mixed over this period. The most recent filing was on Nov 11, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 11, 25 | William F FeeheryCHIEF EXECUTIVE OFFICER | BUY | 24.1K | $8.30 | $200K |
| Sep 9, 25 | Leif E PedersenPRESIDENT, CHIEF COMMERCAL OFF | SELL | 51.2K | $10.92 | $559K |
| Oct 7, 24 | Patrick F SmithPRESIDENT, DRUG DEV SOLUTIONS | SELL | 5.4K | $11.03 | $60K |
| Sep 9, 24 | Leif E PedersenPRESIDENT, CHIEF COMMERCAL OFF | SELL | 51.2K | $11.29 | $578K |
| Apr 2, 24 | Patrick F SmithPRESIDENT, DRUG DEV SOLUTIONS | SELL | 5.3K | $17.77 | $88K |
| Apr 1, 24 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 3.0K | $18.00 | $54K |
| Mar 4, 24 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 3.0K | $18.28 | $55K |
| Feb 20, 24 | Patrick F SmithPRESIDENT, DRUG DEV SOLUTIONS | SELL | 5.0K | $18.00 | $90K |
| Feb 12, 24 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 6.0K | $18.00 | $108K |
| Dec 26, 23 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 6.0K | $18.00 | $108K |
| Sep 11, 23 | Leif E PedersenPRESIDENT, CHIEF COMMERCAL OFF | SELL | 51.2K | $14.60 | $748K |
| Aug 22, 23 | Eran BroshyDirector | BUY | 4.8K | $15.80 | $76K |
| Aug 21, 23 | Eran BroshyDirector | BUY | 193 | $16.10 | $3K |
| Jun 5, 23 | Patrick F SmithPRESIDENT, INTEGRATED DRUG DEV | SELL | 19.1K | $21.55 | $412K |
| May 11, 23 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 5.0K | $20.82 | $104K |
| Apr 14, 23 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 5.0K | $23.66 | $118K |
| Mar 6, 23 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 10.0K | $21.45 | $215K |
| Feb 2, 23 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 15.0K | $20.00 | $300K |
| Dec 8, 22 | Eqt Fund Management S.a R.l.TenPercentOwner | SELL | 29.95M | $15.00 | $449.3M |
| Nov 22, 22 | Leif E PedersenPRESIDENT, SOFTWARE | SELL | 51.2K | $15.55 | $797K |
| Nov 15, 22 | Mason P SlaineDirector | SELL | 245.8K | $15.57 | $3.8M |
| Nov 14, 22 | Mason P SlaineDirector | SELL | 4.2K | $15.27 | $64K |
| Nov 14, 22 | Matthew M WalshDirector | SELL | 12.1K | $14.74 | $178K |
| Nov 9, 22 | Patrick F SmithPRESIDENT, INTEGRATED DRUG DEV | SELL | 2.4K | $13.48 | $32K |
| Aug 19, 22 | Stephen M. McLeanDirector | BUY | 20.0K | $16.32 | $326K |
| Aug 17, 22 | Michael Andrew SchemickCHIEF FINANCIAL OFFICER | BUY | 25.0K | $16.64 | $416K |
| Aug 16, 22 | Eqt Avatar Parent Gp LlcTenPercentOwner | SELL | 6.00M | $17.38 | $104.4M |
| Aug 16, 22 | Mason P SlaineDirector | SELL | 182.5K | $17.38 | $3.2M |
| Aug 16, 22 | Patrick F SmithPRESIDENT, INTEGRATED DRUG DEV | SELL | 10.0K | $17.71 | $177K |
| Jun 8, 22 | Patrick F SmithPRESIDENT, INTEGRATED DRUG DEV | SELL | 10.0K | $19.16 | $192K |
| Jun 2, 22 | Mason P SlaineDirector | SELL | 100.0K | $19.59 | $2.0M |
| May 31, 22 | Eqt Avatar Parent L.p.TenPercentOwner | SELL | 1.50M | $19.00 | $28.5M |
| Apr 4, 22 | Patrick F SmithPRESIDENT, INTEGRATED DRUG DEV | SELL | 3.4K | $22.29 | $75K |
| Mar 17, 22 | Mason P SlaineDirector | SELL | 125.0K | $20.25 | $2.5M |
| Mar 16, 22 | William F FeeheryCHIEF EXECUTIVE OFFICER | SELL | 62.5K | $20.17 | $1.3M |
| Mar 16, 22 | Mason P SlaineDirector | SELL | 125.0K | $20.17 | $2.5M |
| Mar 16, 22 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 3.0K | $20.00 | $60K |
| Mar 11, 22 | William F FeeheryCHIEF EXECUTIVE OFFICER | SELL | 27.5K | $20.29 | $558K |
| Feb 18, 22 | William F FeeheryCHIEF EXECUTIVE OFFICER | SELL | 70.3K | $23.93 | $1.6M |
| Feb 17, 22 | William F FeeheryCHIEF EXECUTIVE OFFICER | SELL | 53.4K | $25.49 | $1.3M |
| Feb 1, 22 | Mason P SlaineDirector | SELL | 35.2K | $26.80 | $934K |
| Jan 26, 22 | William F FeeheryCHIEF EXECUTIVE OFFICER | SELL | 51.2K | $25.67 | $1.3M |
| Jan 26, 22 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 3.0K | $26.01 | $78K |
| Jan 20, 22 | Justin EdgePRES., REGULATORY & ACCESS | SELL | 5.0K | $27.50 | $138K |
| Jan 18, 22 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 5.0K | $27.44 | $137K |
| Jan 3, 22 | Mason P SlaineDirector | SELL | 40.3K | $28.88 | $1.2M |
| Dec 27, 21 | Richard M. TraynorSVP AND GENERAL COUNSEL | SELL | 3.0K | $29.30 | $88K |
| Dec 23, 21 | James E Cashman IIIDirector | SELL | 25.1K | $29.20 | $733K |
| Dec 22, 21 | James E Cashman IIIDirector | SELL | 19.9K | $29.00 | $577K |
| Dec 22, 21 | William F FeeheryCHIEF EXECUTIVE OFFICER | SELL | 75.0K | $28.58 | $2.1M |
Over the past 12 months, insiders at Certara, Inc. filed 1 open-market purchase worth $200K and 1 sale worth $559K on CERT, which makes them mixed over the period. The most recent Form 4 was filed on Nov 11, 25.
The largest recent open-market CERT insider purchase in our data was $416K by Michael Andrew Schemick, CHIEF FINANCIAL OFFICER, filed on Aug 17, 22.
2 different insiders at Certara, Inc. filed open-market SEC Form 4 transactions on CERT over the last 12 months.
InsiderTape plots every CERT insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Certara, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →